Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenobarbitone in previously untreated epilepsy

M Feely, M O'Callagan, B Duggan

    Journal of Neurology, Neurosurgery, and Psychiatry
    |April 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A prototype differential atom interferometer for fundamental physics.

    Nature·2026
    Same author

    Genetics of gait score in broilers: Genetic parameters of gait score in purebred broiler lines.

    Poultry science·2025
    Same author

    Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2022
    Same author

    Overriding water table control on managed peatland greenhouse gas emissions.

    Nature·2021
    Same author

    Efficacy of Topical Vancomycin- and Gentamicin-Loaded Calcium Sulfate Beads or Systemic Antibiotics in Eradicating Polymicrobial Biofilms Isolated from Diabetic Foot Infections within an <i>In Vitro</i> Wound Model.

    Antimicrobial agents and chemotherapy·2021
    Same author

    Uptake of biosimilars for TNF-α inhibitors adalimumab and etanercept following the best-value biological medicine initiative in Ireland.

    International journal of clinical pharmacy·2021
    Same journal

    Global epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Diagnostic accuracy of a two-cut-off approach using the FAQ/MMSE ratio and FAQ for clinical preselection of patients for anti-amyloid therapy.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

    Journal of neurology, neurosurgery, and psychiatry·2026
    Same journal

    Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

    Journal of neurology, neurosurgery, and psychiatry·2026
    See all related articles

    Phenobarbitone effectively controlled seizures in most new epilepsy patients. Higher plasma levels of phenobarbitone (over 43 mumol/l) correlated with better seizure control and no serious side effects were noted.

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
    • Effective antiepileptic drug (AED) therapy is crucial for managing epilepsy and improving patient quality of life.

    Purpose of the Study:

    • To evaluate the efficacy and safety of phenobarbitone in treating new-onset epilepsy patients.
    • To determine the relationship between phenobarbitone plasma levels and seizure control.

    Main Methods:

    • A prospective study involving 13 new epilepsy patients (8 adults, 5 children).
    • Phenobarbitone was administered, and seizure control, compliance, and plasma levels were monitored.
    • Plasma concentrations were measured to achieve steady-state levels.

    Main Results:

    Related Experiment Videos

    • Full seizure control was achieved in 11 out of 13 patients.
    • One patient had poor compliance, and seizures were reduced by over 50% in the remaining two.
    • Mean steady-state plasma phenobarbitone levels above 43 mumol/l were associated with superior seizure control compared to lower doses.
    • No serious adverse events were reported during the study.

    Conclusions:

    • Phenobarbitone demonstrates significant efficacy and a favorable safety profile for treating new epilepsy cases.
    • Maintaining adequate plasma concentrations of phenobarbitone is important for optimizing therapeutic outcomes.
    • Further research may explore optimal dosing strategies for phenobarbitone in diverse epilepsy populations.